Health TrialsbyHealthPanel

The Effect of an Integrated Mobile Health Platform on Early Detection of Clinical Outcomes of Critical Ill Patients

ConditionsMobile Health PlatformClinical Outcomes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSohag University

About this trial

This study will aim to examine the Effect of integrated Mobile Health Platform on early detection of clinical outcomes of Critical ill patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients aged 18-65 years.

Anticipated ICU stay of more than 24 hours.

Clinical requirement and ability to continuously monitor vital signs and urine output.

Obtained written informed consent from the patient or their legal guardians.

Disqualifiers

Patients placed in strict isolation due to highly infectious diseases.

Death within 24 hours of ICU admission.

Patients transferred from another external Intensive Care Unit.

Re-admission to the ICU during the active study period.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Integrated Mobile Health Platform

    Device

    A digital health platform integrated with ICU monitoring systems to automatically collect, record, and analyze patient vital signs and lab trends, generating real-time early warning alerts for healthcare providers.

Treatment groups

250 Participants
are divided into 2 treatment groups
Group A: mHealth Intervention GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

ICU Mortality Rate

The percentage of critically ill patients who die in the General Intensive Care Unit during their hospital stay. This will evaluate the impact of the mHealth platform on reducing patient mortality.

Time frame
From ICU admission up to 30 days.

Secondary outcomes

1

ICU Length of Stay (LOS)

The total number of days each patient spends in the General Intensive Care Unit from the day of admission until discharge.

Time frame
From ICU admission up to 30 days.
2

Incidence of Clinical Complications

The occurrence of organ-specific complications during the ICU stay, including respiratory (pulmonary edema, ARDS, pneumonia, difficult weaning), cardiac (cardiac arrest, shock, arrhythmia), and renal complications (acute renal failure).

Time frame
Daily from study enrollment until ICU discharge, up to 30 days.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: